Sign inJoin waitlistJoin the waitlist

Rohan Garje

Faculty · Florida International University

Credentials: · · · · · ·

History

Florida International University
Present

Infectious Disease
University of Iowa Health Care Medical Center
2017–2019
Hematology and Medical Oncology
Roy J. and Lucille A. Carver College of Medicine
2014–2017
Fairview Hospital-GME
University of Iowa Health Care Medical Center
Osmania Medical College

Research

Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
Review · Cancers · 2020 · 994 citations
Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors
Review · Frontiers in Oncology · 2020 · Last of 4 authors · 151 citations
Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA
Journal for ImmunoTherapy of Cancer · 2020 · 108 citations

Yousef Zakharia
20 papers · 11 as a fellow
Rana McKay
13 papers · 6 as a resident
Andrew Armstrong
12 papers
Deepak Kilari
12 papers
Mehmet Bilen
10 papers
Abhishek Tripathi
9 papers
AA
Ajjai Alva
9 papers
Clara Hwang
9 papers
Michael Schweizer
9 papers
TD
Tanya Dorff
9 papers
Vadim Koshkin
9 papers
Laura Graham
8 papers

Clinical trials

Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
Principal investigator · Recruiting · Phase 2
Baptist Health South Florida
2026–2031
177Lu-PSMA, Niraparib/AA Plus Prednisone for Prostate Cancer
Principal investigator · Withdrawn · Phase 1, Phase 2
Baptist Health South Florida
2024–2028
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2025–2032
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037